Dr. Michael Stephen Trent's lab at the University of Georgia focuses on understanding how Gram-negative bacteria, like Acinetobacter baumannii, develop their protective outer membrane. The research aims to uncover the mechanisms behind the transport and assembly of essential membrane components, which is crucial due to the rising threat of antibiotic resistance. The findings could lead to innovative strategies for designing new antimicrobial treatments that target these formidable pathogens.

Dr. Frederick D. Quinn's lab at the University of Georgia focuses on developing novel vaccines to combat respiratory infections, particularly tuberculosis. Using advanced nanoparticle technology, the lab is researching ways to stimulate local immune responses in the lungs to provide better protection against diseases caused by inhaled pathogens. By combining multiple mycobacterial proteins with immune-boosting components, they aim to create a more effective vaccine that builds on existing methods.

Dr. Xiaorong Lin's lab focuses on developing a vaccine for cryptococcal meningoencephalitis, a severe fungal infection that is particularly dangerous for people with HIV/AIDS. The lab studies the life cycle of the fungus Cryptococcus neoformans, specifically its transition between different forms, to understand how it interacts with the immune system. By harnessing unique immunogenic properties of the fungus, the lab aims to create effective vaccines that can provide protection even for individuals with weakened immune systems.

Dr. Jorge C Escalante's lab at the University of Georgia focuses on understanding how prokaryotic cells, like bacteria, manage their metabolism to adapt to different environments, including during infections. The lab studies specific enzymes that modify other proteins and examines the complex process of making a large coenzyme essential for microbial life. They use advanced techniques to visualize these intricate molecular structures and aim to uncover new therapeutic targets for human diseases related to microbial infections.